Erratum: The Missing Diversity in Human Genetic Studies (Cell (2019) 177(1) (26–31), (S0092867419302314), (10.1016/j.cell.2019.02.048));The Missing Diversity in Human Genetic Studies

Cell

Volumn 177, Issue 1, 2019, Pages 26-31

  Sirugo, Giorgio ^a   Williams, Scott M ^c   Tishkoff, Sarah A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN; ASIAN; BOTTLENECK POPULATION; CYSTIC FIBROSIS; EPISTASIS; EUROPEAN; FAVISM; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HAPLOTYPE; HISPANIC; HOMOZYGOSITY; HUMAN; HUMAN GENETICS; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NONSENSE MUTATION; NOTE; PHARMACOGENETICS; PHARMACOGENOMICS; PLEIOTROPY; POLYGENIC RISK SCORE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; ANCESTRY GROUP; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENETIC VARIATION; PROCEDURES; RISK FACTOR; SELECTION BIAS;

CONTINENTAL POPULATION GROUPS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; GENETIC VARIATION; GENETICS; HUMAN GENETICS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SELECTION BIAS;

EID: 85062640799     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2019.04.032     Document Type: Erratum

References (18)

1. Buxbaum, J., Jacobson, D.R., Tagoe, C., Alexander, A., Kitzman, D.W., Greenberg, B., Thaneemit-Chen, S., Lavori, P., Transthyretin V122I in African Americans with congestive heart failure. J. Am. Coll. Cardiol. 47 (2006), 1724–1725.
2. Curtis, D., Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia. Psychiatr. Genet. 28 (2018), 85–89.
3. Freedman, B.I., Limou, S., Ma, L., Kopp, J.B., APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. Am. J. Kidney Dis. 72:5S1 (2018), S8–S16.
4. Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Uscinski Knob, A.L., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 (2010), 841–845.
5. Johnson, J.A., Caudle, K.E., Gong, L., Whirl-Carrillo, M., Stein, C.M., Scott, S.A., Lee, M.T., Gage, B.F., Kimmel, S.E., Perera, M.A., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update. Clin. Pharmacol. Ther. 102 (2017), 397–404.
6. Khera, A.V., Chaffin, M., Aragam, K.G., Haas, M.E., Roselli, C., Choi, S.H., Natarajan, P., Lander, E.S., Lubitz, S.A., Ellinor, P.T., Kathiresan, S., Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50 (2018), 1219–1224.
7. Kilpeläinen, T.O., Bentley, A.R., Noordam, R., Sung, Y.J., Schwander, K., Winkler, T.W., Jakupović, H., Chasman, D.I., Manning, A., Ntalla, I., et al., Lifelines Cohort Study. Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity. Nat. Commun., 10, 2019, 376.
8. Lim, E.T., Würtz, P., Havulinna, A.S., Palta, P., Tukiainen, T., Rehnström, K., Esko, T., Mägi, R., Inouye, M., Lappalainen, T., et al., Sequencing Initiative Suomi (SISu) Project. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet., 10, 2014, e1004494.
9. Luzzatto, L., The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics. Lancet 376 (2010), 739–741.
10. Mak, A.C.Y., White, M.J., Eckalbar, W.L., Szpiech, Z.A., Oh, S.S., Pino-Yanes, M., Hu, D., Goddard, P., Huntsman, S., Galanter, J., et al., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. Am. J. Respir. Crit. Care Med. 197 (2018), 1552–1564.
11. Martin, A.R., Gignoux, C.R., Walters, R.K., Wojcik, G.L., Neale, B.M., Gravel, S., Daly, M.J., Bustamante, C.D., Kenny, E.E., Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations. Am. J. Hum. Genet. 100 (2017), 635–649.
12. Padoa, C., Goldman, A., Jenkins, T., Ramsay, M., Cystic fibrosis carrier frequencies in populations of African origin. J. Med. Genet. 36 (1999), 41–44.
13. Piel, F.B., Steinberg, M.H., Rees, D.C., Sickle Cell Disease. N. Engl. J. Med. 376 (2017), 1561–1573.
14. Popejoy, A.B., Fullerton, S.M., Genomics is failing on diversity. Nature 538 (2016), 161–164.
15. Rader, D.J., Damrauer, S.M., “Pheno”menal value for human health. Science 354 (2016), 1534–1536.
16. Saleheen, D., Natarajan, P., Armean, I.M., Zhao, W., Rasheed, A., Khetarpal, S.A., Won, H.H., Karczewski, K.J., O'Donnell-Luria, A.H., Samocha, K.E., et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature 544 (2017), 235–239.
17. Stewart, C., Pepper, M.S., Cystic Fibrosis in the African Diaspora. Ann. Am. Thorac. Soc. 14 (2017), 1–7.
18. Tishkoff, S.A., Reed, F.A., Friedlaender, F.R., Ehret, C., Ranciaro, A., Froment, A., Hirbo, J.B., Awomoyi, A.A., Bodo, J.M., Doumbo, O., et al. The genetic structure and history of Africans and African Americans. Science 324 (2009), 1035–1044.